Back

Mechanisms and therapy of diaphragmatic weakness.

1 May 2017 (16:52 - 17:15)
Organised by:
Congress Presentation Part of: How should comorbidities in heart failure be treated? Co-morbidities HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Alain Lacampagne

Laboratory for Cardiovascular Physiology of Montpellier, Montpellier (France)

3 More presentations in this session

Presentation thumbnail
How to approach COPD in heart failure.
Professor M. Lainscak (Murska Sobota, SI)
Slides Video
Presentation thumbnail
All about alcohol and the liver in heart failure.
Professor S. von Haehling (Goettingen, DE)
Presentation thumbnail
The problems of cachexia, sarcopenia and frailty in heart failure: treatment options.
Professor S. Anker (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
How should comorbidities in heart failure be treated?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 16:52 CET
You may be interested in
thumbnail
Congress Presentation
Impact of diaphragm atrophy in elderly patients with heart failure: a multicenter prospective cohort study
28 August 2023
thumbnail
Congress Session
ACNAP Clinical Case Excellence Award
23 June 2023
thumbnail
Congress Presentation
Skeletal muscle-selective deletion of iron regulatory protein 1 and 2 in mice impairs exercise tolerance and cardiac adaptation to increased afterload.
20 May 2023
thumbnail
Congress Presentation
Cardiac contractily modulation: a new therapy for heart failure
13 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources